Analyst call will be held to discuss data today at 4:00 PM Eastern Time NEW YORK– Pfizer Inc. (NYSE: PFE) today announced detailed results from two pivotal studies that make… Read More
Oral presentation on KRYSTEXXA® (pegloticase injection) plus methotrexate to be held June 2, 2022 at 11:35 a.m. CEST. Additional data presentations provide new insights on psychosocial and comorbidity impact of… Read More
Pivotal data on glofitamab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody, in heavily pre-treated patients with aggressive lymphoma, will be presented as part of our industry-leading haematology portfolio Further… Read More
SEATTLE — Chinook Therapeutics, Inc. (Nasdaq: KDNY) today announced the pricing of its underwritten public offering of 6,428,572 shares of its common stock at a price to the public of… Read More
Based on topline data, three doses of the Pfizer-BioNTech COVID-19 Vaccine met all immunobridging criteria required for Emergency Use Authorization The third 3-µg dose was well tolerated among 1,678 children… Read More
